Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)

NCT01597375 is registered in ClinicalTrials.gov with Elliot Israel, MD as lead sponsor.

NCT NCT01597375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
Lead sponsor
Elliot Israel, MD
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
December 14, 2016
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin exacerbated asthma, asthma, aspirin-induced